Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Panopalis, P., et al. - Over the past few decades, advances in the management and treatment of systemic lupus erythematosus have resulted in improved prognosis and greater survival rates. This period has also seen substantial increases in healthcare expenditure. Although improved outcomes offer some justification for an increase in costs, it remains important to examine whether limited healthcare resources are being used in a manner that is efficient and that provides the greatest benefit

Related Articles

Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
Lupus, 11/09/09    Relevance Score: 84%

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09    Relevance Score: 84%

Infection—genetics relationship in systemic lupus erythematosus
Lupus, 11/05/09    Relevance Score: 83%

Molecular mimicry in systemic lupus erythematosus
Lupus, 11/13/09    Relevance Score: 82%

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09    Relevance Score: 82%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address